The conference served as a high-level scientific platform focused on advancing women’s cancer care, with comprehensive discussions spanning early and metastatic breast cancer, gynecologic malignancies, precision oncology, genomics, immunotherapy, and supportive care. The program featured keynote lectures, scientific sessions, and expert panel discussions that highlighted the latest evidence, evolving standards of care, and patient-centered treatment approaches.
Chaired by Dr. Salha Bujassom, the conference welcomed distinguished national and international speakers representing leading academic institutions and global health organizations. Their contributions emphasized the importance of multidisciplinary collaboration, innovation, and equitable access to high-quality cancer care for women.
The strong attendance and active engagement throughout the day reflected the growing commitment within Qatar’s healthcare community to advancing women’s oncology services through science, education, and collaboration.
The Women’s Cancer Conference 2026 concluded with a shared vision to continue strengthening partnerships, translating evidence into practice, and improving outcomes for women affected by cancer.
